Search Within

Marc Ladanyi

  1. "Alexander Drilon"
Formats
  1. Journal Article (61)
  2. Meeting Abstract (59)
  3. Editorial (1)
  4. Guidelines (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (123)
  2. Department of Pathology and Laboratory Medicine (123)
  3. GSK Faculty (123)
  4. Human Oncology and Pathogenesis Program (123)
  5. Solid Tumor Oncology Division (123)
  6. Thoracic Oncology (123)

More Groups

People
  1. Alexander Drilon (123)
  2. Maria Arcila (59)
  3. Mark Kris (46)
  4. Romel Somwar (38)
  5. Gregory Riely (37)
  6. Ryma Benayed (37)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (24)
  2. Journal of Thoracic Oncology (18)
  3. Clinical Cancer Research (16)
  4. Cancer Discovery (7)
  5. Cancer Research (7)
  6. Modern Pathology (7)

More Publications

Publishers
  1. American Association for Cancer Research (32)
  2. American Society of Clinical Oncology (31)
  3. Elsevier Inc. (18)
  4. Nature Publishing Group (10)
  5. Elsevier Science, Inc. (9)
  6. Nature Research (7)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Leveraging RNA from DNA extraction lysate to rescue “insufficient” samples for more comprehensive genomic profiling in patients with scant tumor specimens
    Journal Article

    Ewalt, M. D.; DiNapoli, S. E.; Mullaney, K.; Urvalek, A.; Uh, M. K.; Sukhadia, P.; Killian, J. K.; Zaidinski, M.; Jung, H. J.; McFarlane, T.; more...
    Journal of Molecular Diagnostics (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
    Journal Article

    Febres-Aldana, C. A.; Vojnic, M.; Odintsov, I.; Zhang, T.; Cheng, R.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A. M.; Gili, L.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Germline and somatic MUTYH mutations: Clinicopathologic and mutational analysis in a pan-cancer cohort
    Meeting Abstract

    Desilets, A.; Repetto, M.; Kemel, Y.; Khurram, A.; Mandelker, D.; Bandlamudi, C.; Novak, B.; Velilla, C.; Selenica, P.; Richards, A. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save